Devan V Mehrotra

Devan V Mehrotra

Central US Merck & Co., Inc. - Kenilworth / United States
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 4376406
-
person_outline Devan V Mehrotra's MOST POPULAR ARTICLES
1-) Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialSP Buchbinder, DV Mehrotra, A Duerr, DW Fitzgerald, R Mogg, D Li, ...The Lancet 372 (9653), 1881-1893, 200818982008
2-) HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysisMJ McElrath, SC De Rosa, Z Moodie, S Dubey, L Kierstead, H Janes, ...The Lancet 372 (9653), 1894-1905, 20088422008
3-) Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy AdultsFH Priddy, D Brown, J Kublin, K Monahan, DP Wright, J Lalezari, ...Clinical infectious diseases 46 (11), 1769-1781, 20083102008
4-) Step Study Protocol Team. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialSP Buchbinder, DV Mehrotra, A Duerr, DW Fitzgerald, R Mogg, D Li, ...Lancet 372 (9653), 1881-1893, 20082842008
5-) Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?GF Liu, K Lu, R Mogg, M Mallick, DV MehrotraStatistics in medicine 28 (20), 2509-2530, 20092272009